Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells

BACKGROUND: Cannabidiol (CBD), the main non-psychoactive cannabinoid, has been previously shown by us to ameliorate clinical symptoms and to decrease inflammation in myelin oligodendrocyte glycoprotein (MOG)35-55-induced mouse experimental autoimmune encephalomyelitis model of multiple sclerosis as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neuroinflammation
Main Authors: Kozela, Ewa, Juknat, Ana, Kaushansky, Nathali, Ben-Nun, Avraham, Coppola, Giovanni, Vogel, Zvi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
https://ncbi.nlm.nih.gov/pubmed/25880134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-015-0273-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares